News & insights

Events

30 April 2025 - RNA technologies: pitfalls and patent drafting tips in Europe

In the wake of vaccine development during the COVID-19 pandemic, the value of RNA technologies is at an all-time high.

Requesting a Unitary Patent – What do I need to know?

Since the changes to the European patent system which led to the introduction of the Unitary Patent (UP) and the Unified Patent Court (UPC), we have been assisting more and more clients with obtaining...

Thoughts

Opposition Hotspots: Which medical technology sectors face the highest rate of EPO opposition?

Which MedTech sectors see the most oppositions at the EPO? Which MedTech patents are safer from being revoked or limited via EPO opposition?

Thoughts

Can “public prior use” be relied upon to invalidate European patents?

The “state of the art” for assessing novelty and inventive step at the European Patent Office includes “…everything made available to the public by means of a written or oral description, by use, or i...

Thoughts

LNPs: Small lipids, big potential in nucleic acid delivery

Lipid nanoparticles (LNPs) have emerged as a leading pharmaceutical formulation technology, particularly for nucleic acid delivery.

News

Kilburn & Strode announce this year’s Partner and Counsel promotions

These promotions continue our commitment to advancing our people, investing in everyone's development, whilst looking to our future.

Technical Tips

Prior use ''pitfalls'' – three key tips for success in EPO oppositions

This practical update takes a look at how best to use public prior use in an EPO opposition and the potential pitfalls to avoid.

Case law

At the interface: patenting MedTech software at the EPO

Medical device software and user interfaces are becoming an increasingly important differentiator for medtech companies. New GUIs and data visualisation tools – for clinicians or for patients – may m...

Events

24 March 2025 - Latest lessons from the EPO - 2024 case law review

We would love you to join us for a virtual event on Monday 24 March as Kilburn & Strode’s patent experts reflect on some of the most influential case law that emerged from the EPO last year while iden...